In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA)

Cannabigerol (CBG) and cannabichromene (CBC) are non-psychoactive cannabinoids that have raised increasing interest in recent years. These compounds exhibit good tolerability and low toxicity, representing promising candidates for drug repositioning. To identify novel potential therapeutic targets f...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Molecules
المؤلفون الرئيسيون:	Luca Pinzi, Christian Lherbet, Michel Baltas, Federica Pellati, Giulio Rastelli
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	MDPI AG 2019-07-01
الموضوعات:	drug repurposing molecular modelling cannabinoids ligand-based virtual screening docking BEAR natural products
الوصول للمادة أونلاين:	https://www.mdpi.com/1420-3049/24/14/2567